DD242405A5 - Verfahren zur herstellung einer neuen kristallinen form eines benzothlazindioxid-salzes - Google Patents

Verfahren zur herstellung einer neuen kristallinen form eines benzothlazindioxid-salzes Download PDF

Info

Publication number
DD242405A5
DD242405A5 DD85282869A DD28286985A DD242405A5 DD 242405 A5 DD242405 A5 DD 242405A5 DD 85282869 A DD85282869 A DD 85282869A DD 28286985 A DD28286985 A DD 28286985A DD 242405 A5 DD242405 A5 DD 242405A5
Authority
DD
German Democratic Republic
Prior art keywords
polymorphic form
solvent
dioxide
carboxamide
hydroxy
Prior art date
Application number
DD85282869A
Other languages
German (de)
English (en)
Inventor
Robert L Robertson
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD242405A5 publication Critical patent/DD242405A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L57/00—Protection of pipes or objects of similar shape against external or internal damage or wear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DD85282869A 1984-11-16 1985-11-14 Verfahren zur herstellung einer neuen kristallinen form eines benzothlazindioxid-salzes DD242405A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,028 US4582831A (en) 1984-11-16 1984-11-16 Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor

Publications (1)

Publication Number Publication Date
DD242405A5 true DD242405A5 (de) 1987-01-28

Family

ID=24696846

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85282869A DD242405A5 (de) 1984-11-16 1985-11-14 Verfahren zur herstellung einer neuen kristallinen form eines benzothlazindioxid-salzes

Country Status (28)

Country Link
US (1) US4582831A (fr)
EP (1) EP0182572B1 (fr)
JP (1) JPS61122284A (fr)
KR (1) KR870000291B1 (fr)
CN (1) CN1004001B (fr)
AT (1) ATE50257T1 (fr)
AU (1) AU556378B2 (fr)
CA (1) CA1209572A (fr)
DD (1) DD242405A5 (fr)
DE (1) DE3575925D1 (fr)
DK (1) DK171726B1 (fr)
EG (1) EG17621A (fr)
ES (1) ES8701712A1 (fr)
FI (1) FI82045C (fr)
GR (1) GR852772B (fr)
HU (1) HU197899B (fr)
IE (1) IE58288B1 (fr)
IL (1) IL77051A (fr)
IN (1) IN164207B (fr)
MY (1) MY101984A (fr)
NO (1) NO854574L (fr)
NZ (1) NZ214201A (fr)
PH (1) PH21322A (fr)
PL (1) PL149466B1 (fr)
PT (1) PT81490B (fr)
SU (1) SU1491339A3 (fr)
YU (1) YU44019B (fr)
ZA (1) ZA858773B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
TWI280128B (en) 2002-05-22 2007-05-01 Smithkline Beecham Corp 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
ECSP077628A (es) * 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
WO2010138656A1 (fr) 2009-05-29 2010-12-02 Glaxosmithkline Llc Procédés d'administration de composés agonistes de la thrombopoïétine
CN103626777B (zh) * 2009-07-29 2015-10-21 内尔维阿诺医学科学有限公司 Plk抑制剂的盐类
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
IN160683B (fr) * 1981-06-01 1987-07-25 Pfizer
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
RO88420A (fr) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procede pour la preparation des sels basiques de pyroxycam deposes sur supports pharmaceutiques

Also Published As

Publication number Publication date
GR852772B (fr) 1986-03-14
KR870000291B1 (ko) 1987-02-25
MY101984A (en) 1992-02-29
JPH0425957B2 (fr) 1992-05-06
EG17621A (en) 1991-08-30
PL149466B1 (en) 1990-02-28
DK171726B1 (da) 1997-04-14
AU4995085A (en) 1986-05-22
FI854512A0 (fi) 1985-11-15
ATE50257T1 (de) 1990-02-15
IL77051A (en) 1989-03-31
IE58288B1 (en) 1993-08-25
CN85108245A (zh) 1986-09-03
FI82045B (fi) 1990-09-28
DK527585D0 (da) 1985-11-15
IN164207B (fr) 1989-01-28
PT81490B (pt) 1988-03-03
KR860004038A (ko) 1986-06-16
SU1491339A3 (ru) 1989-06-30
PT81490A (en) 1985-12-01
ZA858773B (en) 1987-06-24
HU197899B (en) 1989-06-28
DK527585A (da) 1986-05-17
IL77051A0 (en) 1986-04-29
EP0182572A1 (fr) 1986-05-28
CN1004001B (zh) 1989-04-26
PH21322A (en) 1987-09-28
AU556378B2 (en) 1986-10-30
JPS61122284A (ja) 1986-06-10
NO854574L (no) 1986-05-20
EP0182572B1 (fr) 1990-02-07
DE3575925D1 (de) 1990-03-15
ES548878A0 (es) 1986-12-01
ES8701712A1 (es) 1986-12-01
YU178585A (en) 1987-12-31
US4582831A (en) 1986-04-15
YU44019B (en) 1990-02-28
HUT40116A (en) 1986-11-28
IE852852L (en) 1986-05-16
FI854512A (fi) 1986-05-17
NZ214201A (en) 1988-07-28
FI82045C (fi) 1991-01-10
CA1209572A (fr) 1986-08-12
PL256259A1 (en) 1986-10-07

Similar Documents

Publication Publication Date Title
DE2858042C2 (de) Rechtsdrehendes Isomer eines asymmetrischen Spirohydantoins sowie der Basensalze hiervon und ihre Verwendung
DE3143219C2 (fr)
DE69400887T2 (de) Sulphonamid-Derivate
EP0212537B1 (fr) Procédé pour la préparation d'une modification stable de torasémide ainsi que médicaments le contenant
DD211560A5 (de) Verfahren zur herstellung kristalliner benzothiazindioxid-salze
DD202568A5 (de) Verfahren zur herstellung wasserloeslicher benzothiazindioxid-salze
DE69001722T2 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
DE3245469C2 (fr)
EP0761650A1 (fr) Modification cristalline thermostable et supportant le stockage du N-méthyle-N-((1S)-1-phényle-2-((3S)-3-hydroxypyrrolidin-1-yl)-éthyle)-2,2-diphényle-acétamide et procédé pour sa préparation
DD242405A5 (de) Verfahren zur herstellung einer neuen kristallinen form eines benzothlazindioxid-salzes
DE2522090A1 (de) Pyrimidinol-verbindungen und verfahren zu ihrer herstellung
DD218349A5 (de) Verfahren zur herstellung von 2-tert.-butylamino-3-chlorpropiophenonmaleat
DE69318046T2 (de) Antikrebsbenzaldehydverbindungen
EP0849264A1 (fr) Nouvelle forme polymorphique de mésylate de doxazosin (forme I)
DE2251559C2 (de) 5,6-Dihydro-pyrrolo[3,4-b]pyridinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE69121807T2 (de) 3-[(5-Methyl-2-furanyl)methyl]-N-(4-piperidinyl)-3H-imidazo[4,5-b]-pyridin-2-amin-2-hydroxy-1,2,3-propantricarboxylat
DE69715196T2 (de) Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)-nipecotinsäure
DE69609314T2 (de) Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung
DE69424816T2 (de) N-Benzylpiperazinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende Zusammensetzungen
DE2513136C3 (de) N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
EP0849265A1 (fr) Nouvelle forme polymorphique de mésylate de doxazosin (forme II)
DE2655130C3 (de) Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes
DE2535599A1 (de) Substituierte zimtsaeureamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende zubereitungen
EP0313935A2 (fr) Enoléthers de 6-chloro-4-hydroxy-2-méthyl-N-(2-pyridyl)-2H-thiéno(2,3-e)-1,2-thiazin-3-carboxamides-1,1-dioxyde, un procédé pour leur préparation et leur utilisation

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee